Clinomics (XKRX:352770) Construction In Progress : ₩0 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Clinomics Construction In Progress?

Clinomics's quarterly construction in progress declined from Sep. 2023 (₩273 Mil) to Dec. 2023 (₩0 Mil) but then stayed the same from Dec. 2023 (₩0 Mil) to Mar. 2024 (₩0 Mil).

Clinomics's annual construction in progress declined from Dec. 2021 (₩1,640 Mil) to Dec. 2022 (₩428 Mil) and declined from Dec. 2022 (₩428 Mil) to Dec. 2023 (₩0 Mil).

Clinomics Construction In Progress Historical Data

The historical data trend for Clinomics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinomics Construction In Progress Chart

Clinomics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

68.00

400.00

1,640.30

427.53

Clinomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial													597.41	273.09	273.09	-	-

Clinomics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Clinomics (XKRX:352770) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinomics Inc (XKRX:352770) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Unist-Gil, Eonyang-eup, Ulju-gun, Ulsan, KOR, 44919

Website

http://www.clinomics.com

Clinomics Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology.

Clinomics (XKRX:352770) Headlines

No Headlines